NASDAQ:CRBP Corbus Pharmaceuticals - CRBP News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Corbus Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $0.14 0.00 (0.00%) (As of 01/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.14▼$0.1550-Day Range$0.11▼$0.1952-Week Range$0.10▼$0.62Volume1.36 million shsAverage Volume1.30 million shsMarket Capitalization$18.13 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Get Corbus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address CRBP Media Mentions By Week CRBP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRBP News Sentiment▼0.620.71▲Average Medical News Sentiment CRBP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRBP Articles This Week▼30▲CRBP Articles Average Week All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCorbus Pharmaceuticals (NASDAQ:CRBP) Receives New Coverage from Analysts at StockNews.comamericanbankingnews.com - January 28 at 6:34 AMCorbus Pharmaceuticals Holdings Inc. stock remains steady Tuesday, still outperforms marketmarketwatch.com - January 24 at 8:47 PMCorbus Pharmaceuticals Holdings Inc. stock rises Thursday, outperforms marketmarketwatch.com - December 15 at 8:09 PMCorbus Pharmaceuticals Holdings Inc. stock falls Wednesday, underperforms marketmarketwatch.com - December 14 at 6:03 PMCorbus Presents Latest Preclinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meetingfinance.yahoo.com - November 10 at 6:01 PMCorbus Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - November 8 at 8:32 AMWhy Qualtrics International Shares Are Trading Sharply Higher; Here Are 23 Stocks Moving Premarketmsn.com - October 25 at 8:43 AMCorbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meetingfinance.yahoo.com - October 14 at 8:11 AMCorbus Pharmaceuticals Appoints Anne Altmeyer, PhD to Board of Directorsfinance.yahoo.com - September 26 at 9:27 AMCorbus Presents First Pre-Clinical Data for CRB-913 at the European Association for the Study of Diabetes 2022 Annual Conferencefinance.yahoo.com - September 22 at 10:08 AMCorbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 12 at 7:59 AMCorbus Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 9 at 8:29 AMCorbus Pharmaceuticals Holdings, Inc. (CRBP)finance.yahoo.com - August 6 at 10:20 PMCorbus Pharmaceuticals: Q1 Earnings Snapshotapnews.com - May 10 at 11:38 AMCorbus Pharmaceuticals GAAP EPS of -$0.08 beats by $0.01seekingalpha.com - May 10 at 11:38 AMCorbus Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Updatemarkets.businessinsider.com - May 10 at 11:38 AMMarijuana Stock Movers For April 18, 2022msn.com - April 18 at 5:44 PMCorbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meetingfinance.yahoo.com - April 8 at 5:43 PMCorbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitorsmarketwatch.com - April 7 at 9:41 PMCitius (CTXR) Posts Top-Line Data From Pivotal Lymphoma Studymsn.com - April 7 at 11:41 AMCannabis Stock Gainers And Losers From April 5, 2022msn.com - April 5 at 7:20 PMCorbus Pharmaceuticals Holdings Inc. stock falls Monday, underperforms marketmarketwatch.com - April 4 at 6:56 PMCorbus Pharmaceuticals to Present at the Oppenheimer 32nd Annual Healthcare Conferencefinance.yahoo.com - March 11 at 8:42 AMCorbus Pharmaceuticals: Q4 Earnings Insightsbenzinga.com - March 8 at 10:29 AMCorbus Pharmaceuticals Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Corporate Updatesfinance.yahoo.com - March 8 at 10:29 AMAkari Therapeutics Appoints Rachelle Jacques as President and Chief Executive Officerfinance.yahoo.com - March 2 at 7:39 AMClever Leaves Expands Deal With Cannatrek In Australia Via $3.6M Sales Agreement To Include THC Flowerbenzinga.com - February 15 at 10:58 PMCannabis Stock Gainers And Losers From February 2, 2022msn.com - February 2 at 6:53 PMCRBP Jan 2023 2.500 callsg.finance.yahoo.com - January 22 at 6:03 PMMindset Pharma Teams Up With The McQuade Center To Develop 2 Families Of Novel Psychedelic Compoundsbenzinga.com - January 21 at 8:56 PMCorbus Pharmaceuticals Holdings Inc Shares Near 52-Week Low - Market Movernasdaq.com - January 19 at 10:50 PMCannabis Stock Gainers And Losers From January 12, 2022msn.com - January 12 at 8:09 PMCannabis Stock Gainers And Losers From January 6, 2022msn.com - January 6 at 6:53 PMHere's Why You Should Hold Onto Acadia Healthcare (ACHC) Nowfinance.yahoo.com - December 31 at 1:50 PMAfter Plunging 29.4% in 4 Weeks, Here's Why the Trend Might Reverse for Corbus Pharmaceuticals (CRBP)msn.com - December 29 at 11:24 AMDown 31.4% in 4 Weeks, Here's Why You Should You Buy the Dip in Corbus Pharmaceuticals (CRBP)finance.yahoo.com - December 7 at 2:20 PMCorbus Pharmaceuticals Holdings Inc. stock rises Friday, still underperforms marketmarketwatch.com - November 13 at 8:34 AMCorbus Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Corporate Updatesfinance.yahoo.com - November 12 at 9:49 AMCorbus Pharmaceuticals Holdings Inc. stock outperforms market on strong trading daymarketwatch.com - November 8 at 8:08 PMWill Corbus Pharmaceuticals (CRBP) Report Negative Q3 Earnings? What You Should Knowfinance.yahoo.com - November 2 at 7:58 PMCorbus Pharmaceuticals Completes $27.2 Million Registered Direct Offeringfinance.yahoo.com - October 26 at 7:37 AMuniQure Announces the Appointment of Rachelle Jacques to its Board of Directorsfinance.yahoo.com - October 21 at 10:17 AMCould The Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Ownership Structure Tell Us Something Useful?finance.yahoo.com - September 10 at 7:57 AMRecap: Corbus Pharmaceuticals Q2 Earningsbenzinga.com - August 12 at 4:30 PMCorbus Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides Corporate Updatesfinance.yahoo.com - August 12 at 4:30 PMCorbus Pharmaceuticals (CRBP) Reports Q2 Loss, Lags Revenue Estimatesfinance.yahoo.com - August 12 at 4:30 PMCorbus Pharmaceuticals (CRBP) May Report Negative Earnings: Know the Trend Ahead of Q2 Releasefinance.yahoo.com - July 29 at 5:41 PMCorbus Pharmaceuticals Holdings, Inc. Common Stock (CRBP)nasdaq.com - July 23 at 6:58 PMCorbus shares fall as autoimmune drug fails another late-stage trialbizjournals.com - June 24 at 2:29 PMCorbus Says DETERMINE Phase 3 Study Of Lenabasum Did Not Meet Primary Endpoint - Quick Factsmarkets.businessinsider.com - June 24 at 9:28 AM Get Corbus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBP and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:CRBP) was last updated on 1/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.